Home
Public services
Dashboard
Curated content
Companies
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Companies
Corridor Pharmaceuticals
Save
Corridor Pharmaceuticals
Launch date
2007
Employees
2-10 people
Market cap
-
Enterprise valuation
CAD71—106m
(Dealroom.co estimates Jun 2010.)
Towson Maryland (HQ)
http://corridorpharma.com
https://www.linkedin.com/company/corridor-pharmaceuticals-inc-
B2B
B2C
biotechnology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Patents (2)
Corridor Pharmaceuticals funding
Corridor Pharmaceuticals investors
Edit
Date
Investors
Amount
Round
Oct 2008
Quaker Bio Ventures
MedImmune Ventures
Red Abbey Venture Partners
Acidophil
$2.3m
Angel
Oct 2009
MedImmune Ventures
Red Abbey Venture Partners
Osage University Partners
Quaker Partners
$10.8m
Series A
Jun 2010
Quaker Bio Ventures
MedImmune Ventures
Red Abbey Venture Partners
Maryland Health Care Product Development
Osage University Partners
NewSpring Capital
$13.0m
Series A
Jan 2013
N/A
$1.6m
Debt
Total Funding
CAD35.6m
Recent News about Corridor Pharmaceuticals
Edit
Investments by Corridor Pharmaceuticals
Edit
Immune Control
ACQUISITION by Corridor Pharmaceuticals Jun 2010